Codexis, Inc.

Codexis is a leading enzyme engineering company that leverages its proprietary CodeEvolver® platform to discover and develop high-performance enzymes. These enzymes serve as critical biocatalysts in the commercial manufacture of pharmaceuticals, fine chemicals, and food ingredients, as well as for use in molecular biology and diagnostic applications. In recent years, the company has pivoted its strategic focus toward the 'ECO Synthesis' (Enzyme-Catalyzed Oligonucleotide Synthesis) platform. This technology aims to revolutionize the manufacturing of RNAi therapeutics by replacing traditional chemical synthesis with a more scalable, sustainable, and cost-effective enzymatic route, addressing the growing demand for siRNA and other nucleic acid-based medicines.